(Q43636305)

25 November 2017

Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium (English)

1 reference

25 November 2017

2

1 reference

25 November 2017

Jaberansari MT

1

1 reference

25 November 2017

Muller CA

3

1 reference

25 November 2017

Latouf SE

4

1 reference

25 November 2017

Röth E

5

1 reference

25 November 2017

Opie LH

6

1 reference

25 November 2017

Yellon DM

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Journal of the American College of Cardiology

25 November 2017

1 reference

25 November 2017

37

1 reference

25 November 2017

1996-2001

1 reference

25 November 2017

7

1 reference

Ischaemic preconditioning: present position and future directions.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Ramiprilat increases bradykinin outflow from isolated hearts of rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

The nitric oxide hypothesis of late preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Coronary collateral circulation in the pig: correlation of collateral flow with coronary bed size.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Infarct Size Reduction by Ischemic Preconditioning Is a Monophasic, Short-Lived Phenomenon in Anesthetized Pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Role of bradykinin in protection of ischemic preconditioning in rabbit hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in guinea-pig isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Role of kinins in the endothelial protective effect of ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901232-3

7 January 2021

10.1016/S0735-1097(01)01232-3

Identifiers

DOI

1 reference

25 November 2017

1 reference